Kristina Gifft
Interventional Cardiology · Columbia, MONPI 1427588235
Payments from drug & device makers
Across 313 payments — averaging $51.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Teleflex LLC$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
- Amgen$1K
- Boston Scientific$885
- Abiomed$872
- plus $3K from 21 others
What the payments were for
- Grants$6,00037%
- Travel & lodging$1,98612%
- Food & beverage$7,44046%
- Education$5063%
- Gifts$841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 27 | $7,520 |
| Teleflex LLC | 7 | $1,873 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 75 | $1,047 |
| Amgen | 54 | $1,047 |
| Boston Scientific | 19 | $885 |
| Abiomed | 21 | $872 |
| Novartis | 41 | $511 |
| Edwards Lifesciences | 7 | $444 |
| Penumbra, Inc. | 2 | $265 |
| Chiesi USA, Inc. | 10 | $258 |
| E.r. Squibb & Sons, L.L.C. | 12 | $242 |
| Asahi Intecc USA, Inc. | 3 | $152 |
| Johnson & Johnson | 8 | $137 |
| Abbott | 5 | $129 |
| Shockwave Medical, Inc | 1 | $123 |
| AstraZeneca | 3 | $108 |
| Pfizer | 4 | $60 |
| Alnylam Pharmaceuticals Inc. | 3 | $53 |
| Grifols USA, LLC | 1 | $51 |
| Janssen Scientific Affairs, LLC | 1 | $45 |
| La Jolla Pharmaceutical Company | 2 | $41 |
| Cordis US CORP. | 2 | $38 |
| Acist Medical Systems, Inc. | 1 | $34 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $26 |
| Philips North America LLC | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Biotronik Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,016 in reported general payments places this provider in the 55th percentile of 182 interventional cardiology providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 26 | $206 |
| ClopidogrelClopidogrel Bisulfate | 31 | $159 |
| Atorvastatin Calcium | 20 | $86 |
| Rosuvastatin Calcium | 11 | $55 |
| Furosemide | 11 | $47 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Columbia
- Kul AggarwalColumbia$523K
- Taishi HiraiColumbia$310K
- Poorna KaruparthiColumbia$245K
- Albert ChanColumbia$91K
- Michael BrownColumbia$40K
- Harvey SerotaSaint Louis$7.1M
- Adnan ChhatriwallaKansas City$3.6M
- Gil VardiSaint Louis$2M
- Alan ZajariasSaint Louis$1.6M
- James GranthamKansas City$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.